DM2 is a metabolic disorder characterized by hyperglycemia, which may be due to a defect in insulin secretion of pancreatic β cells, insulin resistance in peripheral tissues, and/or an excessive accumulation of triglycerides and fatty acid derivatives in skeletal muscles. The gene discussed is INS; the disease is myotonic dystrophy type 2.